Skip to content
Triangle logo TriangleGet started
← Back to this collection

PUBLICATIONS · 32701411

Anti-CD30 CAR-T Cell Therapy in Relapsed and Refractory Hodgkin Lymphoma.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
J Clin Oncol
Publication date
2020 Nov 10
First author
Ramos CA

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Nat Rev Clin Oncol. 2020 Oct;17(10):592. doi: 10.1038/s41571-020-0425-8.
    note
    Source null
    related pmid
    32753735
    relationship
    Comment in

Authors and identifiers

  1. name
    Ramos CA
    type
    Author
  2. name
    Grover NS
    type
    Author
  3. name
    Beaven AW
    type
    Author
  4. name
    Lulla PD
    type
    Author
  5. name
    Wu MF
    type
    Author
  6. name
    Ivanova A
    type
    Author
  7. name
    Wang T
    type
    Author
  8. name
    Shea TC
    type
    Author
  9. name
    Rooney CM
    type
    Author
  10. name
    Dittus C
    type
    Author
  11. name
    Park SI
    type
    Author
  12. name
    Gee AP
    type
    Author
Complete bibliographic record and source provenance
authors
  1. name
    Ramos CA
    type
    Author
  2. name
    Grover NS
    type
    Author
  3. name
    Beaven AW
    type
    Author
  4. name
    Lulla PD
    type
    Author
  5. name
    Wu MF
    type
    Author
  6. name
    Ivanova A
    type
    Author
  7. name
    Wang T
    type
    Author
  8. name
    Shea TC
    type
    Author
  9. name
    Rooney CM
    type
    Author
  10. name
    Dittus C
    type
    Author
  11. name
    Park SI
    type
    Author
  12. name
    Gee AP
    type
    Author
bibliography ids
  1. nci-bib-38e871ae0749214926780dce
book metadata
content sha256
0587d842bb38c485809dd12805cbbd3251dd2ac99209df687960c66146a26bd0
document type
citation
dois
  1. 10.1200/JCO.20.01342
electronic publication date
display
2020 Jul 23
precision
day
year
2020
evidence scope
bibliographic_metadata_only
id
pubmed:32701411
immutable id
pubmed:32701411@0587d842bb38c485809dd12805cbbd3251dd2ac99209df687960c66146a26bd0
journal
abbreviation
J Clin Oncol
issn electronic
1527-7755
issn print
0732-183X
issue
32
name
Journal of clinical oncology : official journal of the American Society of Clinical Oncology
nlm unique id
8309333
pages
3794-3804
volume
38
languages
  1. eng
notices
absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Nat Rev Clin Oncol. 2020 Oct;17(10):592. doi: 10.1038/s41571-020-0425-8.
    note
    Source null
    related pmid
    32753735
    relationship
    Comment in
outcomes validated
false
pmid
32701411
provenance
batch id
40d9eae1f1d369f13109
provider
NCBI PubMed ESummary
record sha256
af97943f5350e5e525192bc0bb15ecf01ec803052ef0a894cc94793db2884770
response sha256
03fa1567b6babd78281d8ec4529596b9d4953c2c4ac23257dca371d609645ba9
retrieved at
2026-09-09T23:47:52.637547+00:00
publication date
display
2020 Nov 10
precision
day
year
2020
publication types
  1. Clinical Trial, Phase I
  2. Clinical Trial, Phase II
  3. Journal Article
  4. Multicenter Study
  5. Research Support, N.I.H., Extramural
  6. Research Support, Non-U.S. Gov't
record status
PubMed - indexed for MEDLINE
schema version
1.0
source url
https://pubmed.ncbi.nlm.nih.gov/32701411/
title
Anti-CD30 CAR-T Cell Therapy in Relapsed and Refractory Hodgkin Lymphoma.

Preserved source evidence · Not medical advice